Virios Therapeutics, Inc. (VIRI) Social Stream



Virios Therapeutics, Inc. (VIRI): $0.48

0.00 (-0.95%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add VIRI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#180 of 347

in industry

VIRIOS THERAPEUTICS INC (VIRI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering VIRIOS THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 1 $22 $22 $22 $0.662 3223.26%
2022-08-15 1 $22 $12 $17 $0.662 2467.98%
2022-09-19 1 $12 $7 $9.5 $0.662 1335.05%
2023-05-16 1 $2 $2 $2 $0.662 202.11%
2023-11-13 1 $3.5 $3.5 $3.5 $0.662 428.7%

Price Target Last Issued November 15, 2021

The Trend in the Analyst Price Target


Over the past 31 months, VIRI's average price target has gone down $11.5.

Over the past 26 weeks, VIRI's average upside potential has been 201.29%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-16 1 2.0 2.0 2.0 1.030 94.17%
2023-07-24 1 3.5 3.5 3.5 2.150 62.79%
2023-08-15 1 3.5 3.5 3.5 1.020 243.14%
2023-11-13 1 3.5 3.5 3.5 0.693 405.05%

VIRI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


Over the past 20 months, VIRI's average broker recommendation rating worsened by 2.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, VIRIOS THERAPEUTICS INC's number of analysts covering the stock is greater than nearly none of them.
  • To contextualize these metrics, consider that out of all US stocks, VIRIOS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 573.85% of them.
  • In terms of how VIRIOS THERAPEUTICS INC fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -43.17% of that group.
  • In terms of how VIRIOS THERAPEUTICS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 99.79% of that group.

Stocks similar to VIRIOS THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IPA, QLI, and BPTS.

Is VIRI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!